STI Testing to Support HIV Prevention Use in Pregnant Women in Botswana
Tests STI screening alongside PrEP offers in pregnant women in Botswana.
Plain-language title generated from the registry record
Registry title: STI Testing to Enhance PrEP Use in Pregnancy
Key facts
- Where
- Gaborone, BotswanaSee the site
- Phase
- Phase 3
Where in Botswana
- DHMT ClinicsGaborone, BotswanaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Botswana Harvard AIDS Institute Partnership
- Trial code
- NCT06919614
- Record updated
- 11 June 2026
- Original description
The investigators are conducting a study in Botswana to see if offering STI testing along with expanded HIV prevention options (PrEP) helps more pregnant women start and continue using PrEP during and after pregnancy. Pregnant women (n=600) seeking antenatal care in Botswana will be enrolled and randomly assigned to receive the standard of care (standard STI assessment with no STI testing) versus STI testing for Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis during pregnancy and postpartum. The investigators' hypothesis is that providing STI testing alongside PrEP offer will encourage more women to start and continue using PrEP.Read full original descriptionShow less
Improving PrEP Outcomes Among Pregnant Women in Botswana With an Integrated STI Testing and PrEP Delivery Model
The investigators are conducting a study in Botswana to see if offering STI testing along with expanded HIV prevention options (PrEP) helps more pregnant women start and continue using PrEP during and after pregnancy. Pregnant women (n=600) seeking antenatal care in Botswana will be enrolled and randomly assigned to receive the standard of care (standard STI assessment with no STI testing) versus STI testing for Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis during pregnancy and postpartum. The investigators' hypothesis is that providing STI testing alongside PrEP offer will encourage more women to start and continue using PrEP.
Inclusion: Pregnant and seeking antenatal care; Self-identifying as a cis-gender woman; Living without HIV; Not currently using PrEP; Planning to remain in the city/town of enrolment until 9 months post-delivery; Planning to receive antenatal and postnatal care in the city/town of enrolment; Willing and able to provide informed consent.
Exclusion: Currently using PrEP; Living with HIV; Male gender; Not pregnant; Not planning to remain in the city/town of enrolment until 9 months post-delivery; Not planning to receive antenatal and postnatal care in the city/town to enrolment; Not able or willing to provide informed consent for participation.